Feb 6 (Reuters) - Cyclopharm Ltd CYC.AX
* Confirms it remains on track to record initial sales of ultralutetm in first half of 2017
* Expects to report record sales revenue for 2016 full year of $14.4 million and underlying EBITDA of approximately $3.4 million Source text for Eikon: ID:nASX6H8dxz Further company coverage: CYC.AX